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A case of Midget-faded Rattlesnake (Crotalus oreganus concolor) envenoming to an adult male 
professional herpetologist occurred in a rural setting and resulted in what appeared as an array of 
venom induced myo-neurological symptoms. The patient experienced blurry vision, total body 
paresthesia, dyspnea, chest tightness, and waves of spastic muscle movements of the hands and 
feet that appeared like tetany. These symptoms were confounding as to whether they were 
potentially venom induced or were related to stress-induced physiological responses. Local 
envenomation effects were minimal, and coagulation parameters remained within normal limits. 
Antivenom was not administered per patient concerns related to a prior history of acute allergic 
reactions to antivenom. Venom was collected from the C. o. concolor responsible for the bite, 
and analysis revealed the presence of high levels of myotoxins (SR calcium pump antagonists), 
and concolor toxin, a presynaptic neurotoxin that can cause myotoxic effects and respiratory 
paralysis; several serine proteinases associated with coagulopathies were also present in the 
venom profile. 
 










The Midget-faded Rattlesnake (Crotalus oreganus concolor) is an uncommon, small (50-65 cm 
total body length) subspecies originally assigned to the Crotalus viridis complex, and currently 
recognized as a subspecies in the Crotalus oreganus clade.1-2 It is indigenous to a restricted 
geographic range of the Colorado Plateau that includes west-central Colorado, the Colorado and 
Green River basins, eastern Utah, southwestern Wyoming, and extreme northern Arizona.3,4,5  
Crotalus o. concolor venom studies have revealed the presence of a potent lethal toxin, 
antigenically similar to Mojave toxin.6-7 It has been determined to be one of the most lethal 
crotaline venoms, nearly equal in toxicity to Crotalus durissus terrificus and Crotalus scutulatus 
scutulatus venoms, based on murine lethality experiments.8 Additionally, it has been reported 
that C. o. concolor venom lethality ranges from 10-30 fold greater than multiple other crotaline 
species.8-9 A presynaptic phospholipase A2-ß-neurotoxin (concolor toxin) and nonenzymatic 
peptide myotoxins have been identified as major venom components.9-12 
Envenoming of humans by C. o. concolor is rare, and the case reported here illustrates 
what clinically appeared to be possible venom induced myo-neurological symptoms that were 
confounded in interpretation by physiological stresses. Analysis of venom from the C. o. 
concolor responsible in this case suggested a possible correlation between specific venom 
components and several observed clinical symptoms.  
Case Presentation 
A healthy 61-y-old male, professional herpetologist sustained a bite from a captive (wild caught) 
adult male C. o. concolor (Figure 1 A). Patient history included prior crotaline envenomings 
from Crotalus horridus, C. h. atricaudatus (subspecies recognized at the time of the bite) and 
Crotalus durissus ruruima. Treatments involved Wyeth anticrotalic antivenoms and Instituto 
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Butantan anticrotalico, with anaphylactic reactions having occurred. Patient medication history 
included migraine headache prescriptions (rizatriptan, atenolol, and amitriptyline).  
The incident took place in a remote facility, and the bite occurred as the snake was being 
removed from a drawer-type housing unit, resulting in a single fang puncture into the right 
thumb (Figure 1 B). Immediately, the patient experienced generalized “pins and needles” 
sensations in the bitten thumb that rapidly progressed to pain, followed by tingling of the lips, 
and feeling chest tightness. Within 15 min the patient reported total body tingling. The first 
responder found the patient resting supine on the floor, and reported the patient did not appear 
anxious or agitated, with no obvious signs of hyperventilation (20 breaths min-1). The patient 
described feeling like he was “wearing a clay mask and a hat with hat band one size too small 
constricting around my forehead”. The affected limb was splinted for immobilization during a 1 
h ground ambulance transport to the helispot, and subsequent 45 min helicopter flight to a rural 
hospital. During ground transport the patient complained of breathing difficulty, and 
supplemental oxygen was provided via nasal cannula. Tightening of the tongue, blurred vision, 
and difficulty speaking were also experienced. Three distinct waves of transient neuromuscular 
spasms associated with inspirational weakness ensued. Spastic simultaneous contractures of first 
the left hand, and 2nd to a lesser degree the right (bitten) hand and foot/toes, followed by a 3rd 
wave that involved the left forearm, lower leg and foot. The first responder described these 
waves as severe spastic muscle movement, tetany like (Figure 2 A). The patient was alert and 
oriented; blood pressure was normal by sphygmomanometer/cuff (113/72 mm Hg), and pulse 
normal by palpitation (69 beats min-1) (Figure 2 B).  
Approximately 2 1/2 h postbite the patient arrived to the emergency department, and the 
myo-neurological symptoms had abated. Examination revealed a single fang puncture in the 
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distal phalangeal region of the right thumb and swelling that extended proximally to the thenar 
eminence. Chemistry panel, complete blood count, electrolytes, coagulation and hematological 
parameters were within normal limits excepting a slightly elevated D-dimer (566 ng mL-1 FEU; 
reference lab range 190-490 ng mL-1 FEU), and elevated creatine kinase (CK) 3394 U L-1 
(reference lab range 22-198 U L-1). Over the following 24 h there was a small decline in total 
serum calcium from 8.8 mg dL-1 (3 h) to 7.7 mg dL-1 (22 h) (reference lab range 8.5-10.1 mg dL-
1), and a corresponding slight decline in serum albumin from 4.2 g dL-1 (3 h) to 3.5 g dL-1 (22 h) 
(reference lab range 3.4-5.0 g dL-1).  There was no evidence of bleeding at any time. Swelling 
spread proximally to mid-forearm over the first 3 h, but local pain had lessened. Medical staff 
observed patient total body strength weakness with poor coordination, requiring walking frame 
assistance. There was no evidence of compartment syndrome. Despite indications for antivenom 
its administration was declined by the patient because of anaphylactic reactions from previous 
antivenom treatments. The patient was observed for another 6 h and discharged at 25 h postbite 
(22 h post admission) in stable condition. At 24 h after discharge the patient remained weak, but 
could walk without assistance. Myalgia in the right arm and generalized weakness persisted for 
several days. At 3 weeks follow-up the bitten thumb skin sloughed, thumb numbness persisted, 
but other local symptoms had resolved completely, and all laboratory studies were unremarkable. 
Venom from the offending C. o. concolor was collected for assay and analysis of venom 
components and their potential correlation to observed symptoms.  
Methods - Venom Analysis 
Venom was extracted manually from the C. o. concolor responsible for the bite approximately 4 
days after the bite, centrifuged to pellet the cell debris, and the supernatant lyophilized (fluid 
yield 120 µL; ≈ 27 mg dry venom). Lyophilized venom was solubilized in PBS (8.0 mg mL-1), 
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and 200 µL (1.6 mg) was subjected to reversed phase high performance liquid chromatography 
(RP-HPLC) as reported previously; 1 min fractions were collected and lyophilized.13 Toxins 
were identified from the known elution profiles of purified toxins and quantified via peak area 
integration (% total area). 
HPLC fractions were also subjected to polyacrylamide gel electrophoresis (SDS-PAGE) 
under reducing conditions to identify chromatogram peaks.13 Crude venom was assayed for 
protein content via Pierce BCA assay, and then for 6 enzyme activities common to rattlesnake 
venoms.10,14 These data were used in conjunction with HPLC chromatogram data to identify 
protein families present and their relative abundance in the venom.  
Discussion and Results 
Our patient’s symptoms illustrate a potential diagnostic conundrum clinicians may face in cases 
of snakebite envenoming: what symptoms might be venom induced effects, and what symptoms 
might be related to stress induced physiological responses?  Our patient experienced generalized 
paresthesia, blurred vision, waves of spastic tetany like symptoms of the hands and feet 
(carpopedal spasms), breathing difficulties, numbness, and generalized weakness that persisted 
for days, all symptoms consistent with venom induced effects reported in other cases of North 
American rattlesnake envenoming, including C. o. concolor.9,15,16,17 However, in our patient the 
tetany like carpopedal spasms may not have been venom induced, but likely from patient anxiety 
induced hyperventilation, or triggered by sphygmomanometer cuff inflation.18-19 Crotalus o. 
concolor venom contains myotoxic and neurotoxic components capable of eliciting neurotoxic 
symptoms.9-10,12 Purified C. o. concolor venom toxins injected into mice elicit myotoxic effects 
of rapid ataxia, hind limb extension, and respiratory distress.7,20 Collectively, symptoms in the 
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presented case combined with the interpretation of the inflicting snake’s venom analysis provides 
for interesting discussion. 
Venomous snakebite can trigger significant anxiety leading to an autonomic response of 
hyperventilation-induced alkalemia with consequent precipitation of hypocalcemia resulting in 
symptoms of breathlessness and paresthesia of the face and hands, yet blood pressure remains 
normal.18 Tetany like symptoms of painful sharp involuntary flexion of the wrist and ankle joints 
(carpopedal spasms), cramps, and muscle twitching may be clinically misleading. These 
physiological responses are due to decreased extracellular ionized calcium resulting in a 
hyperexcitability state of muscles and nerves.18 Ionized serum calcium was not measured in our 
patient; however, the patient was not observed to be tachypnic, though hyperventilation may 
occur via slow deep breathing. Hypocalcemic tetany of the lower extremities has been reported 
in a case of Crotalus scutulatus envenoming with minimal coagulopathy, but was thought to 
have been subsequent to rhabdomyolysis.21 Our patient had a normal blood pressure and may 
have deeply hyperventilated to the point of respiratory alkalosis followed by hypocalcemic 
tetany. The carpopedal symptoms fit the profile of stress related physiological responses, which 
were considered a contributing root of cause.  
Blood pressure measurement via sphygmomanometer with an inflatable cuff was used for 
monitoring our patient’s blood pressure during ambulance transport. Cuff inflation, in 
conjunction with hyperventilation induced hypocalcemia, likely triggered a classic Trousseau 
sign.19 Cuff inflation to greater than the mean arterial pressure can result in the hand adopting a 
posture of metacarpophalangeal joint flexion, and the interphalangeal joints of the fingers and 
thumb extended so that the thumb is in an opposing posture, as observed in our patient (Figure 
2B). This phenomenon has been reported in 1-4% of healthy individuals, but has not been 
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reported to be associated with cases of snakebite envenoming.19 Although C. o. concolor 
myotoxic venom components can induce muscle contractile activity, causing rapid tetany like 
hind limb hyperextension in mice, a symptom somewhat similar to the extension of the ankles, 
feet, and toes as observed in our patient, this symptom was likely a stress induced response rather 
than venom induced 20,22  
Our patient’s other myo-neurological symptoms of paresthesia, respiratory distress, and 
total body weakness may possibly have been related to the high myotoxin content and concolor 
toxin in the C. o. concolor’s venom (Figure 3, Table 2). Studies in mice injected with C. o. 
concolor venom showed they died from rapid respiratory failure, suggesting that venom possibly 
may have contributed to our patient’s respiratory difficulty, as has been reported to occur 
following C. scutulatus, C. cerastes, C. oreganus helleri, and C. horridus envenomations.16-17,23-
24  
Venom was delivered to our patient via a single fang puncture, and it is reasonable to 
assume it was not a maximum dose and a potential reason for the reduced severity and duration 
of envenoming symptoms. Neurotoxic effect duration following snake envenoming is highly 
variable.25. The short duration of myo-neurological actions in our patient may possibly have been 
related to dose-dependent pharmacokinetics or pharmacokinetic metabolic actions on a 
responsible toxin.  
Myokymia has been reported following envenoming by C. o. concolor and other North 
American rattlesnakes.15,26-27 In our patient, the periodic episodes of tetany like, carpopedal 
spasms were distinctly different than myokymia or fasciculations.15,27   
Crotaline envenomation can result in hematological effects ranging from mild to severe 
coagulopathy, and neurologically from paresthesia to seizures, and coma. Consequently, patients 
 9 
can exhibit multiple combinations of clinical manifestations varying in severity. 28 Thus, the 
absence of hematological effects in our patient, in the presence of neurological symptoms, was 
not uncharacteristic of rattlesnake envenoming.  Neurological symptoms following C. cerastes 
and C. concolor envenoming, without hematological effects, have been reported.9,15-17  
Local wound complications in our patient were modest, including ecchymosis, swelling, 
pain, and skin sloughing. Elevated creatine kinase (CK), a routinely used marker for tissue 
damage and myonecrosis, has been reported in 2 cases of C. o. concolor envenoming (ranging 
from 1800 – 17,000 IU L-1), and in the absence of coagulopathic complications.15,29  
Our patient’s elevated CK value (3394 U L-1) at 22 h post envenoming was indicative of venom 
induced local tissue/muscle damage to the bitten thumb.  
Medications may potentially influence snake envenoming symptoms, and our patient’s 
medications (atenolol, rizatriptan, and amitriptyline) have reported adverse effects of blurred 
vision, numbness, chest tightness, paresthesia, and weakness similar to our patient’s 
symptoms.30-31 Our patient reported having no adverse effects to these medications prior to the 
bite, suggesting drug/venom interactions were noncontributory to observed symptoms.  
Venom analyses from the responsible snake revealed abundant PLA2-based ß neurotoxin 
(concolor toxin), and nonenzymatic peptide myotoxins.9,12,32 Enzyme analyses revealed the 
presence of 6 enzymes common to rattlesnake venoms (Table 1); however, their levels varied 
significantly from averaged values based on 22 taxa of rattlesnakes.33 Notably, snake venom 
metalloproteinase activity (SVMP; azocasein metalloproteinase) was barely detectable, and this 
likely was responsible for the lack of hemorrhage, rhabdomyolysis or inflammation. These very 
low levels of SVMPs are characteristic of type II venoms, including that of C. o. concolor.10 
Thrombin-like and kallikrein-like serine proteinase activities in the venom were quite high, and 
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thrombin-like activity was nearly twice the average value of many rattlesnake venoms. Because 
of these high activity levels coagulopathies including hypofibrinogenemia would have been 
expected; however, lab blood panels did not indicate any form of coagulopathy. Phospholipase 
A2 levels were moderate, but not noteworthy compared to other species; PLA2 activity is 
sometimes associated with severe inflammation, myotoxicity, and occasionally renal 
damage/failure. The lack of these symptoms indicates that this acidic PLA2 was not particularly 
toxic, consistent with similar enzymatic PLA2s from other species. 
RP-HPLC analysis of the venom (Figure 3) indicated the presence of myotoxins I & II, 
small peptide components common to the venoms of numerous species of rattlesnakes.31 In 
humans, they may be responsible for fasciculations [possibly muscle weakness, both acute and 
prolonged].25 The myotoxin content of this venom was extremely high and comprised > 59% of 
the total venom proteins; concolor toxin made up > 21% of the venom total protein content 
(Figure 3, Table 2). The combined actions of these two protein families, comprising >80% of 
venom proteins, possibly contributed to the rapid paraesthesias and other tetany like symptoms 
observed in the patient. 
Conclusions 
The case reported here is an interesting academic case in that certain symptoms, similar to 
previously reported C. o. concolor cases of envenoming, were potentially a hybridization of 
anxiety and stress induced symptoms integrated with venom induced symptoms. Analyses of 
ionized calcium, arterial blood gases, and a formal patient neurological evaluation would have 
provided for a more comprehensive assessment for confirming or ruling out the source of some 
symptoms. Although the venom profile of the snake involved showed a high myotoxin content 
their role in the myo-neurological (carpopedal spasms) symptoms is unlikely. Thus, the 
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presented case illustrates a diagnostic conundrum, and medical personnel should be cognizant of 
the potential for confounding symptoms associated with rattlesnake envenoming, and 
interpretation as to their cause.  
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Figure 1. Panel A: The midget faded rattlesnake (Crotalus oreganus concolor) responsible 
for the bite, in its housing drawer enclosure from which it struck, imparting a single fang 
puncture to the patient. Panel B: Single fang puncture into the distal phalangeal region of 
the right thumb. 
 
Figure 2. Panel A: Tetany-like spasms showing flexion of the hands and extension of the 
feet (carpopedal spasms) that began 30 min post bite.  Three waves of approximately 10 
min each, 20 min apart, were observed. Panel B: Blood pressure and pulse were normal to 
low as measured by palpitation and the sphygmomanometer/cuff placed on the 
contralateral arm. 
 
Figure 3. RP-HPLC chromatogram of Crotalus oreganus concolor venom, 1.6 mg in 200 µL 
PBS. Identification of peaks are based on SDS-PAGE and enzyme activity assays. Inset: 









Table 1. Assays of Crotalus o. concolor venom for enzyme activities common to rattlesnake 
venoms. Activity levels in the offending venom relative to averages of 22 taxa of 
rattlesnakes (Mackessy, 2008) are also indicated. 
 
  Enzyme Assayed        Specific Activity      Relative Activity  
Phospholipase A2 (nmol product/min/mg)  25.4   ↓ 
 
Azocasein metalloproteinase (Abs 342nm/min/mg) 0.01   ↓↓ 
 
Kallikrein-like (nmol product/min/mg)   971   ↑↑ 
 
Thrombin-like (nmol product/min/mg)              1389   ↑↑ 
 
Phosphodiesterase (Abs 400nm/min/mg)    1.0   ↑ 
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L-amino acid oxidase (nmol product/min/mg)   9.7   ↓ 
              
↓, venom activity lower than average; ↑, venom activity higher than average  
